查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1820079

2025-2033年经皮给药系统市场技术、应用与地区报告

Transdermal Drug Delivery Systems Market Report by Technology, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球透皮给药系统市场规模达71亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到115亿美元，2025-2033年期间的复合年增长率（CAGR）为5.22%。推动市场发展的因素多种多样，包括糖尿病、心血管疾病和神经系统疾病等慢性疾病的盛行率不断上升、老年人口不断增长以及监管审批的不断增加。

透皮给药系统市场趋势：

慢性病盛行率不断上升

由于久坐不动的生活方式和不良的饮食习惯，人们越来越容易患上糖尿病、心臟病、类风湿性关节炎、高血压和神经系统疾病等慢性疾病。患有这些疾病的患者需要长期持续服药，促使他们寻求可靠且便捷的给药方式。透皮贴片是最佳选择，因为它可以持续稳定地输送药物，无需频繁使用。对能够提高患者依从性的非侵入性且易于使用的替代疗法的需求日益增长，这推动了透皮给药系统市场的成长。使用经皮给药系统的患者只需定期贴上贴剂，这有助于降低漏服的可能性。慢性病患者正在寻找更方便的解决方案。根据世界神经病学联合会的数据，一项开创性的全球疾病负担 (GBD) 研究表明，到 2050 年，脑部疾病患者人数预计将翻倍。

老年人口不断增加

随着老龄化人口对透皮给药系统的需求日益增长，市场规模也不断扩大。随着年龄的增长，人们常常会患上多种慢性疾病，包括神经系统疾病、糖尿病、类风湿性关节炎和心血管疾病。老年人可能难以长期坚持服用这些药物。老年人无法吞嚥药物是另一个典型问题。经皮给药系统提供了一种便捷的替代方案，因为它可以避免口服药物，并提供一种非侵入性持续释放药物的方法。此外，老年人对更简单的解决方案的需求日益增长，以减轻每日多次服药的负担，这为透皮给药系统市场带来了良好的前景。世界卫生组织 (WHO) 称，到 2050 年，80 岁及以上老年人口预计将达到 4.26 亿。

监管批准不断增加

中国国家药品监督管理局 (NMPA) 于2023年10月31日批准绿叶製药集团的新型药物利斯的明每週两次透皮贴剂，用于治疗轻度至中度阿兹海默症 (AD)。监管机构正在越来越多地批准更广泛的透皮贴片产品。这涵盖了用于荷尔蒙替代、疼痛缓解甚至免疫接种等一系列药物的贴片。透皮贴片系统正变得越来越普及和多样化，吸引了越来越多的患者和医疗保健专业人员。

透皮给药系统市场细分：

按技术划分：

  • 电穿孔
  • 射频
  • 离子电渗透疗法
  • 微孔化
  • 热的
  • 机械阵列
  • 超音波
  • 其他的

离子电渗透疗法占大部分市场份额

离子电渗透疗法利用微弱电流促进药物经皮扩散。它因其能够精准输送药物剂量并降低副作用而备受青睐。它特别适用于疼痛管理、局部治疗和全身给药，使其成为透皮市场的首选。它是一种非侵入性疗法，对于希望避免注射或口服药物的患者来说，尤其是在需要长期或频繁给药的情况下，是一种更理想的选择。

按应用分类：

  • 中枢神经系统
  • 疼痛管理
  • 心血管
  • 荷尔蒙
  • 其他的

疼痛管理占产业最大份额

个人对疼痛管理的日益关注推动了市场的成长。透皮贴片系统能够持续且可控制地释放止痛药物，对慢性疼痛患者非常有益。这避免了频繁服药的需要，为患者带来了更大的便利。透皮贴片是口服药物和注射剂的非侵入性替代方案。用于疼痛管理的透皮给药系统透过持续低剂量给药，提供了一种减少阿片类药物用量的替代方案，既能有效控制疼痛，又能降低药物滥用的可能性。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美引领市场，占据最大的透皮给药系统市场份额

该报告还对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告指出，北美是透皮给药系统最大的区域市场。

北美拥有完善的医疗保健体系，并拥有尖端的医疗技术。由于支持其使用和分销的基础设施完善，该地区的患者和医疗保健提供者更有可能采用先进的药物输送系统。北美，尤其是美国，慢性病发生率高，需要对患者进行长期持续的药物管理。此外，该地区老年人口的不断增长也推动了市场的成长。根据城市研究所 (Urban Institute) 报告，预计到 2040 年，65 岁及以上的美国人数量将达到 8,000 万人。

（请注意，这只是关键参与者的部分名单，完整名单将在报告中提供。）

  • 顶尖企业正专注于开发适用于各种治疗领域的新型透皮系统。一些公司也在开发能够输送更大分子（包括生物製剂）的贴片。此外，一些关键企业正在将透皮系统的应用扩展到精神健康治疗领域。许多公司正在与研究机构、生技公司和其他製药公司建立合作关係，共同开发或授权新的透皮技术。他们还获得了资金和产品审批，这正在增强市场成长。 2023年9月26日，Satio获得了美国国立卫生研究院、美国卫生与公众服务部高级研究计画署（ARPA-H）350万美元的资助，用于开发一种新型家用远端可控透皮给药装置SatioRx(TM)。

本报告回答的关键问题：

  • 全球透皮给药系统市场迄今表现如何，未来几年将如何表现？
  • 全球市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表最具吸引力的市场？
  • 基于技术的市场区隔是怎样的？
  • 市场上最有吸引力的技术是什么？
  • 根据应用，市场是如何分類的？
  • 市场上最有吸引力的应用程式是什么？
  • 市场的竞争结构是怎么样的？
  • 全球透皮给药系统市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 全球透皮给药系统市场迄今表现如何，未来几年将如何表现？
  • 全球市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表最具吸引力的市场？
  • 基于技术的市场区隔是怎样的？
  • 市场上最有吸引力的技术是什么？
  • 根据应用，市场是如何分類的？
  • 市场上最有吸引力的应用程式是什么？
  • 市场的竞争结构是怎么样的？
  • 全球透皮给药系统市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球透皮给药系统市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依技术

  • 电穿孔
  • 射频
  • 离子电渗透疗法
  • 微孔化
  • 热的
  • 机械阵列
  • 超音波
  • 其他的

第七章：市场区隔：依应用

  • 中枢神经系统
  • 疼痛管理
  • 心血管
  • 荷尔蒙
  • 其他的

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第九章：SWOT分析

第 10 章：价值链分析

第 11 章：波特五力分析

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3M Company
    • Acrux Limited
    • Boehringer Ingelheim International GmbH
    • Hisamitsu Pharmaceutical Co. Inc.
    • Lavipharm SA
    • LEAD CHEMICAL Co. Ltd.
    • Luye Pharma Group
    • Nutriband Inc.
    • Viatris Inc.
Product Code: SR112025A3983

The global transdermal drug delivery systems market size reached USD 7.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.22% during 2025-2033. There are various factors that are driving the market, which include the growing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and neurological disorders, rising geriatric population, and increasing regulatory approvals.

Transdermal Drug Delivery Systems Market Trends:

Growing Prevalence of Chronic Diseases

People are becoming prone to chronic illnesses like diabetes, heart disease, rheumatoid arthritis, hypertension, and neurological disorders because of sedentary lifestyles and poor eating habits. Patients with these disorders need to take medication continuously for a longer time, which prompts them to look for reliable and convenient drug delivery options. For this, transdermal patches work best as they provide a steady flow of medication throughout time without requiring frequent use. The rising demand for non-invasive and easy-to-use alternative that can enhance patient compliance is impelling the transdermal drug delivery systems market growth. Patients using transdermal systems just need to apply a patch on a regular basis, which helps to lower the possibility of missing doses. People with chronic diseases are looking for solutions that offer enhanced convenience. According to the World Federation of Neurology, a groundbreaking new Global Burden of Disease (GBD) study shows that the number of people living with brain disease is expected to double by 2050.

Increasing Geriatric Population

The market is expanding as a result of the growing need for transdermal medication delivery systems among the aging population. People frequently acquire several chronic illnesses as they get older, including neurological disorders, diabetes, rheumatoid arthritis, and cardiovascular ailments. It might be difficult for elderly individuals to take these medications consistently over an extended period. The inability of the elderly to swallow medications is another typical problem. Transdermal drug delivery systems offer a convenient alternative because of their ability to bypass the need to take oral medications and provide a non-invasive method for sustained drug release. Furthermore, the growing need for simpler solutions among older individuals that lowers the burden of multiple daily doses is offering a favorable transdermal drug delivery systems market outlook. The World Health Organization (WHO) claims that the number of people aged 80 years or older is expected to reach 426 million by 2050.

Rising Regulatory Approvals

The National Medical Products Administration (NMPA) of China approved Luye Pharma Group's novel medicine, Rivastigmine Twice Weekly Transdermal Patch, on October 31, 2023, for the symptomatic treatment of mild to moderate Alzheimer's disease (AD). Regulatory agencies are increasingly approving a broader range of transdermal products. This covers patches for a range of medicinal applications such as hormone replacement, pain relief, and even immunizations. Transdermal systems are becoming more widely available and varied, which is drawing in more patients and healthcare professionals.

Transdermal Drug Delivery Systems Market Segmentation:

Breakup by Technology:

  • Electroporation
  • Radiofrequency
  • Iontophoresis
  • Microporation
  • Thermal
  • Mechanical Arrays
  • Ultrasound
  • Others

Iontophoresis accounts for the majority of the market share

Iontophoresis uses a small electric current to improve the diffusion of drugs via the skin. It is favored because of its ability to deliver precise dosages of medication while lowering side effects. It is especially useful for pain management, localized treatment, and systemic drug delivery, making it a leading choice in the transdermal market. It is non-invasive approach, which makes it a preferable alternative for patients who wish to avoid injections or oral medications, especially when long-term or frequent drug administration is required.

Breakup by Application:

  • Central Nervous System
  • Pain Management
  • Cardiovascular
  • Hormone
  • Others

Pain management holds the largest share of the industry

The rising focus on pain management among individuals is contributing to the market growth. Transdermal systems provide continuous and controlled release of pain-relieving medications, which is highly beneficial for chronic pain sufferers. This avoids the need for frequent dosing, making it more convenient for patients. Transdermal patches are a non-invasive alternative to oral medications and injections. Transdermal drug delivery systems for pain management provide an opioid-sparing alternative by delivering low and sustained doses that can manage pain effectively while reducing abuse potential.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest transdermal drug delivery systems market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for transdermal drug delivery systems.

North America has a well-established healthcare system with access to cutting-edge medical technologies. Patients and healthcare providers in the region are more likely to adopt advanced drug delivery systems owing to the availability of infrastructure that supports their use and distribution. North America, particularly the United States, faces high prevalence of chronic diseases, requiring long-term and consistent medication management among individuals. Apart from this, the rising geriatric population in the region is bolstering the market growth. The number of Americans aged 65 and older is predicted to reach 80 million in 2040, as reported by the Urban Institute.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the transdermal drug delivery systems industry include 3M Company, Acrux Limited, Boehringer Ingelheim International GmbH, Hisamitsu Pharmaceutical Co. Inc., Lavipharm S.A., LEAD CHEMICAL Co. Ltd., Luye Pharma Group, Nutriband Inc. and Viatris Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • Top players are focusing on developing new transdermal systems for various therapeutic areas. Companies are also developing patches that deliver larger molecules including biologics. Moreover, key players are expanding the use of transdermal systems into mental health treatments. Many companies are entering into partnerships with research institutions, biotechnology firms, and other pharmaceutical companies to co-develop or license new transdermal technologies. They are also receiving funding and product approvals, which is strengthening the market growth. On 26 September 2023, Satio received funding of US$ 3.5 million by the Advanced Research Projects Agency for Health (ARPA-H), National Institutes of Health, Department of Health and Human Services to develop SatioRx(TM) a novel at-home, remotely controllable transdermal drug delivery device.

Key Questions Answered in This Report:

  • How has the global transdermal drug delivery systems market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global market?
  • What is the impact of each driver, restraint, and opportunity on the global market?
  • What are the key regional markets?
  • Which countries represent the most attractive market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global transdermal drug delivery systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transdermal Drug Delivery Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Electroporation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Radiofrequency
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Iontophoresis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Microporation
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Thermal
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Mechanical Arrays
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Ultrasound
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Central Nervous System
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pain Management
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Hormone
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Acrux Limited
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Boehringer Ingelheim International GmbH
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Hisamitsu Pharmaceutical Co. Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Lavipharm S.A.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 LEAD CHEMICAL Co. Ltd.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Luye Pharma Group
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Nutriband Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Viatris Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials

List of Figures

  • Figure 1: Global: Transdermal Drug Delivery Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Transdermal Drug Delivery Systems Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Transdermal Drug Delivery Systems Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Transdermal Drug Delivery Systems Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Transdermal Drug Delivery Systems Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Transdermal Drug Delivery Systems (Electroporation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Transdermal Drug Delivery Systems (Electroporation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Transdermal Drug Delivery Systems (Radiofrequency) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Transdermal Drug Delivery Systems (Iontophoresis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Transdermal Drug Delivery Systems (Microporation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Transdermal Drug Delivery Systems (Microporation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Transdermal Drug Delivery Systems (Thermal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Transdermal Drug Delivery Systems (Thermal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Transdermal Drug Delivery Systems (Mechanical Arrays) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Transdermal Drug Delivery Systems (Ultrasound) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Transdermal Drug Delivery Systems (Ultrasound) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Transdermal Drug Delivery Systems (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Transdermal Drug Delivery Systems (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Transdermal Drug Delivery Systems (Central Nervous System) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Transdermal Drug Delivery Systems (Pain Management) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Transdermal Drug Delivery Systems (Pain Management) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Transdermal Drug Delivery Systems (Cardiovascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Transdermal Drug Delivery Systems (Hormone) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Transdermal Drug Delivery Systems (Hormone) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Transdermal Drug Delivery Systems (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Transdermal Drug Delivery Systems (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: North America: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: North America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: United States: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: United States: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Canada: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Canada: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Asia-Pacific: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Asia-Pacific: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: China: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: China: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Japan: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Japan: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: India: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: India: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: South Korea: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: South Korea: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Australia: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Australia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Indonesia: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Indonesia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Europe: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Europe: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Germany: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Germany: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: France: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: France: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: United Kingdom: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: United Kingdom: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Italy: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Italy: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Spain: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Spain: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Russia: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Russia: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Latin America: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Latin America: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Brazil: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Brazil: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Mexico: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Mexico: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Middle East and Africa: Transdermal Drug Delivery Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Middle East and Africa: Transdermal Drug Delivery Systems Market: Breakup by Country (in %), 2024
  • Figure 81: Middle East and Africa: Transdermal Drug Delivery Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Global: Transdermal Drug Delivery Systems Industry: SWOT Analysis
  • Figure 83: Global: Transdermal Drug Delivery Systems Industry: Value Chain Analysis
  • Figure 84: Global: Transdermal Drug Delivery Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transdermal Drug Delivery Systems Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Transdermal Drug Delivery Systems Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Transdermal Drug Delivery Systems Market: Competitive Structure
  • Table 6: Global: Transdermal Drug Delivery Systems Market: Key Players